Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus
about
Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiologyMemory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.Determining the breadth of the respiratory syncytial virus-specific T cell responseThe number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouseIL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in miceCo-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV diseaseRecombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease.Depletion of alveolar macrophages ameliorates virus-induced disease following a pulmonary coronavirus infection.Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsetsQuantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think.Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.Cell-mediated immune responses to respiratory syncytial virus infection: magnitude, kinetics, and correlates with morbidity and ageThe comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination.Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease.Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model.The host response and molecular pathogenesis associated with respiratory syncytial virus infection.Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.Prospects for defined epitope vaccines for respiratory syncytial virus.Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.
P2860
Q21133803-8C10D2A4-A078-4CC1-88E1-8BBCD7370730Q30390932-7581925B-0D90-4187-BB88-5B8FBAE18253Q30411070-DEC6E8F4-AADE-4623-896B-CF28FE1B3867Q30437797-1780BE98-C000-4816-A86A-B884D718A935Q34043293-EE365396-6509-41D3-9271-01061E84E70DQ34185860-E3A606F6-668A-4C54-AC82-8A452F22BCF0Q34224973-BD23A926-0CB6-43D9-BA8A-72550A38F7E1Q34504791-0B18B2C8-3D63-4E07-BDE0-B7D52605E0B8Q34791209-BF6B4F03-B481-44CA-BC5B-9165EC1EEAFEQ35070176-ED28D230-CAB8-4E68-B0CD-C6EDB77D0B9DQ35070505-5249F63C-8D39-4AD3-8F86-3275FDFA5A63Q35114458-63385792-4FC8-4745-AE8F-3B8FBC878150Q35131346-5FC5367A-46C3-49BC-863D-23332BC3CBF6Q35174945-F757C86C-E03A-4F02-A667-760E81B6F7DCQ35566829-ECC509EC-E9A1-4D36-9669-D8027013B71EQ35868095-557A8137-04BC-4799-8C75-45FF8A246299Q36281893-D59D2F8D-6C05-425A-9FB6-1D08E64FD9F1Q36482753-FE2E0FE0-92CD-4990-B6D1-F977A9FD527AQ36977881-4C5821D3-3A2C-400F-BB5D-6998C7299550Q36978676-709184C2-60A4-42F1-8A2A-BBAD112D8CA7Q36993991-3F40A692-DA98-4F05-B3B4-2683E7B86963Q37000731-E3F95131-D9C7-4189-A401-C9DF27ECEB69Q37071608-C2A87CB4-A380-428D-9B5F-7FDFDD21C202Q37147650-AC90CE20-17AB-4702-A1CB-842440F8AEFBQ37263779-2A521A44-A52B-485D-BEFB-49D86ACCCDEEQ37649439-5FF1A1CD-D32F-4470-B382-E683DF334EA9Q37721415-9119DFE0-5638-4338-96CF-51050D06C724Q40355982-C0E0FC71-8104-49E5-894C-71A07FE1487EQ42138587-56DF4C4F-43F8-40ED-8A12-FC812034A827
P2860
Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Differential role of gamma int ...... th respiratory syncytial virus
@ast
Differential role of gamma int ...... th respiratory syncytial virus
@en
type
label
Differential role of gamma int ...... th respiratory syncytial virus
@ast
Differential role of gamma int ...... th respiratory syncytial virus
@en
prefLabel
Differential role of gamma int ...... th respiratory syncytial virus
@ast
Differential role of gamma int ...... th respiratory syncytial virus
@en
P2860
P356
P1433
P1476
Differential role of gamma int ...... th respiratory syncytial virus
@en
P2093
Elaine M Castilow
Matthew R Olson
P2860
P304
P356
10.1128/JVI.01949-07
P577
2007-12-19T00:00:00Z